/Investor DB

Ripple Ventures — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Nicoyanicoyalife.comin𝕏Jan 2018 · $2M

Nicoya provides digital biosensing instruments for biophysical characterization, enabling scientists to study molecular behavior and protein interactions in drug discovery and structural analysis.

BiotechDeep TechHardwareHealthtechMedical Devices

Ryan Denomme(CEO)in

Co-investorsGarage CapitalGraphite VenturesInnovative Solutions CanadaMaple Leaf AngelsWaterloo Accelerator CentreWhitecap Venture Partners+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.